The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies
Open accessAbstract
The vascular endothelial growth factor (VEGF) and its receptor (VEGFR) have been shown to play major roles not only in physiological but also in most pathological angiogenesis, such as cancer. VEGF belongs to the PDGF supergene family characterized by 8 conserved cysteines and functions as a homodimer structure. VEGF-A regulates angiogenesis and vascular permeability by activating 2 receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk1 in mice). On the other hand, VEGF-C/VEGF-D and their receptor, VEGFR-3 (Flt-4), mainly regulate lymphangiogenesis. The VEGF family includes other interesting variants, one of which is the virally encoded VEGF-E and another is specifically expressed in the venom of the habu snake (Trimeresurus flavoviridis). VEGFRs are distantly related to the PDGFR family; however, they are unique with respect to their structure and signaling system. Unlike members of the PDGFR family that strongly stimulate the PI3K-Akt pathway toward cell proliferation, VEGFR-2, the major signal transducer for angiogenesis, preferentially utilizes the PLCγ-PKC-MAPK pathway for signaling. The VEGF-VEGFR system is an important target for anti-angiogenic therapy in cancer and is also an attractive system for pro-angiogenic therapy in the treatment of neuronal degeneration and ischemic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, BACE1 is also responsible for ectodomain cleavage of vascular endothelial growth factor receptor 1 (VEGFR1), a receptor important in the regulation of angiogenesis and vascular permeability.”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [135]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., Lilenbaum, R., & Johnson, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061884 · Cited by 5,761
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., et al. (2001) · Nature Medicine · doi:10.1038/87904 · Cited by 1,672
Casanovas, O., Hicklin, D. J., Bergers, G., & Hanahan, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.005 · Cited by 1,621
Kendall, R. L., & Thomas, K. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10705 · Cited by 1,394
Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis
Shibuya, M., & Claesson-Welsh, L. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.11.012 · Cited by 1,062
Self-citationHiratsuka, S., Minowa, O., Kuno, J., Noda, T., & Shibuya, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9349 · Cited by 1,062
Self-citationAutocrine VEGF Signaling Is Required for Vascular Homeostasis
Lee, S., Chen, T. T., Barber, C. L., Jordan, M. C., Murdock, J., Desai, S., Ferrara, N., Nagy, A., Roos, K. P., & Iruela-Arispe, M. L. (2007) · Cell · doi:10.1016/j.cell.2007.06.054 · Cited by 1,046
Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Dorpe, J. V., Hellings, P., Gorselink, M., Heymans, S., et al. (2001) · Nature Genetics · doi:10.1038/88842 · Cited by 1,007
Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H., & Sato, M. (1990) · PubMed · Cited by 960
Self-citationHiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., & Shibuya, M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00153-8 · Cited by 910
Self-citationTakahashi, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2768 · Cited by 749
Molecular mechanisms of lymphangiogenesis in health and disease
Alitalo, K., & Carmeliet, P. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00051-x · Cited by 734
Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization
Fukumura, D., & Jain, R. K. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.05.003 · Cited by 691
Corneal avascularity is due to soluble VEGF receptor-1
Ambati, B. K., Nozaki, M., Singh, N., Takeda, A., Jani, P. D., Suthar, T., Albuquerque, R. J. C., Richter, E., Sakurai, E., Newcomb, M. T., et al. (2006) · Nature · doi:10.1038/nature05249 · Cited by 684
Self-citationTakahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
Self-citationDetmar, M., Brown, L. F., Schön, M. P., Elicker, B. M., Velasco, P., Richard, L., Fukumura, D., Monsky, W., Claffey, K. P., & Jain, R. K. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00262.x · Cited by 550
Meyer, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.2.363 · Cited by 509
Storkebaum, E., Lambrechts, D., Dewerchin, M., Moreno-Murciano, M.-P., Appelmans, S., Oh, H., Van Damme, P., Rutten, B., Man, W. Y., De Mol, M., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1360 · Cited by 494
Maes, C., Carmeliet, P., Moermans, K., Stockmans, I., Smets, N., Collen, D., Bouillon, R., & Carmeliet, G. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00601-3 · Cited by 456
Muller, Y. A., Li, B., Christinger, H. W., Wells, J. A., Cunningham, B. C., & de Vos, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7192 · Cited by 452
Ogawa, S., Oku, A., Sawano, A., Yamaguchi, S., Yazaki, Y., & Shibuya, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31273 · Cited by 406
Self-citationKoga, K., Osuga, Y., Yoshino, O., Hirota, Y., Ruimeng, X., Hirata, T., Takeda, S., Yano, T., Tsutsumi, O., & Taketani, Y. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021942 · Cited by 403
Cell Transformation by the Viral src Oncogene
Jove, R., & Hanafusa, H. (1987) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.03.110187.000335 · Cited by 401
Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice
Sakurai, Y., Ohgimoto, K., Kataoka, Y., Yoshida, N., & Shibuya, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404984102 · Cited by 330
Self-citationPaclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
(2007) · New England Journal of Medicine · doi:10.1056/nejmx070002 · Cited by 327
Role of Vegf-Flt Receptor System in Normal and Tumor Angiogenesis
(1995) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60716-2 · Cited by 323
Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus
Lyttle, D. J., Fraser, K. M., Fleming, S. B., Mercer, A. A., & Robinson, A. J. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.84-92.1994 · Cited by 303
VEGF receptor‐2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis
Matsumoto, T., Bohman, S., Dixelius, J., Berge, T., Dimberg, A., Magnusson, P., Wang, L., Wikner, C., Qi, J. H., Wernstedt, C., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600709 · Cited by 292
Sawano, A., Takahashi, T., Yamaguchi, S., Aonuma, M., & Shibuya, M. (1996) · PubMed · Cited by 290
Self-citationWise, L. M., Veikkola, T., Mercer, A. A., Savory, L. J., Fleming, S. B., Caesar, C., Vitali, A., Makinen, T., Alitalo, K., & Stacker, S. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3071 · Cited by 272
Zuniga, R. M., Torcuator, R., Jain, R., Anderson, J., Doyle, T., Ellika, S., Schultz, L., & Mikkelsen, T. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9718-y · Cited by 272
Van de Veire, S., Stalmans, I., Heindryckx, F., Oura, H., Tijeras-Raballand, A., Schmidt, T., Loges, S., Albrecht, I., Jonckx, B., Vinckier, S., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.039 · Cited by 256
Lawson, N. D., Mugford, J. W., Diamond, B. A., & Weinstein, B. M. (2003) · Genes & Development · doi:10.1101/gad.1072203 · Cited by 233
Vascular Endothelial Growth Factor-B–Deficient Mice Display an Atrial Conduction Defect
Aase, K., von Euler, G., Li, X., Pontén, A., Thorén, P., Cao, R., Cao, Y., Olofsson, B., Gebre-Medhin, S., Pekny, M., et al. (2001) · Circulation · doi:10.1161/01.cir.104.3.358 · Cited by 197
Wu, Y., Hooper, A. T., Zhong, Z., Witte, L., Bohlen, P., Rafii, S., & Hicklin, D. J. (2006) · International Journal of Cancer · doi:10.1002/ijc.21865 · Cited by 192
Murakami, M., Iwai, S., Hiratsuka, S., Yamauchi, M., Nakamura, K., Iwakura, Y., & Shibuya, M. (2006) · Blood · doi:10.1182/blood-2006-04-016030 · Cited by 166
Self-citationPlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth
Bais, C., Wu, X., Yao, J. J., Yang, S., Crawford, Y., McCutcheon, K. M., Tan, C., Kolumam, G. A., Vernes, J.-M., Eastham‐Anderson, J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.033 · Cited by 163
Self-citationFlt-1 Signaling in Macrophages Promotes Glioma Growth In vivo
Kerber, M., Reiss, Y., Wickersheim, A., Jugold, M., Kiessling, F. M., Heil, M., Tchaikovski, V., Waltenberger, J. L., Shibuya, M., Plate, K. H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6241 · Cited by 156
Self-citationExpression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma
Pritchard‐Jones, R., Dunn, D., Qiu, Y., Varey, A. H. R., Orlando, A., Rigby, H., Harper, S. J., & Bates, D. O. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603839 · Cited by 133
Sakaue-Sawano, A., Takahashi, T., Yamaguchi, S., & Shibuya, M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7327 · Cited by 129
Self-citationTakahashi, H., Hattori, S., Iwamatsu, A., Takizawa, H., & Shibuya, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403687200 · Cited by 123
Self-citationMcColl, B., Paavonen, K., Karnezis, T., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7060com · Cited by 121
RACK1 Regulates VEGF/Flt1-mediated Cell Migration via Activation of a PI3K/Akt Pathway
Wang, F., Yamauchi, M., Muramatsu, M., Osawa, T., Tsuchida, R., & Shibuya, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.165605 · Cited by 109
Self-citationMuramatsu, M., Yamamoto, S., Osawa, T., & Shibuya, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0202 · Cited by 103
Self-citationWada, S., Tsunoda, T., Baba, T., Primus, F. J., Kuwano, H., Shibuya, M., & Tahara, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3759 · Cited by 102
Self-citationVEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice
Kiba, A., Sagara, H., Hara, T., & Shibuya, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)03033-4 · Cited by 96
Self-citationKondo, K., Hiratsuka, S., Subbalakshmi, E., Matsushime, H., & Shibuya, M. (1998) · Gene · doi:10.1016/s0378-1119(98)00006-7 · Cited by 87
Self-citationXiong, Y., Huo, Y., Chen, C., Zeng, H., Lu, X., Wei, C., Ruan, C., Zhang, X., Hu, Z., Shibuya, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.019679 · Cited by 63
Self-citationDhondt, J., Peeraer, E., Verheyen, A., Nuydens, R., Buysschaert, I., Poesen, K., Geyte, K. V., Beerens, M., Shibuya, M., Haigh, J. J., et al. (2011) · The FASEB Journal · doi:10.1096/fj.10-170944 · Cited by 60
Self-citationVEGFR2-PLCγ1 axis is essential for endothelial specification of VEGFR2+ vascular progenitor cells
Sase, H., Watabe, T., Kawasaki, K., Miyazono, K., & Miyazawa, K. (2009) · Journal of Cell Science · doi:10.1242/jcs.049908 · Cited by 43
Zheng, Y., Watanabe, M., Kuraishi, T., Hattori, S., Kai, C., & Shibuya, M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000256459.06671.3c · Cited by 42
Self-citationHypoxia and low‐nutrition double stress induces aggressiveness in a murine model of melanoma
Osawa, T., Muramatsu, M., Watanabe, M., & Shibuya, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01105.x · Cited by 38
Self-citationCell Transformation By The Viral SRC Oncogene
Jove, R. (1987) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.3.1.31 · Cited by 32
Role of bevacizumab therapy in the management of glioblastoma
Levin, V. A. (2010) · Cancer Management and Research · doi:10.2147/cmar.s6103 · Cited by 24
Cited by
Comprehensive review of targeted therapy for colorectal cancer
Xie, Y.-H., Chen, Y.-X., & Fang, J.-Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0116-z · Cited by 1,687
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
Kim, N., Kim, H. K., Lee, K., Hong, Y., Cho, J. H., Choi, J. W., Lee, J.-I., Suh, Y.-L., Ku, B. M., Eum, H. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16164-1 · Cited by 1,274
Immune phenotypic linkage between colorectal cancer and liver metastasis
Liu, Y., Zhang, Q., Xing, B., Luo, N., Gao, R., Yu, K., Hu, X., Bu, Z., Peng, J., Ren, X., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.02.013 · Cited by 451
Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation
Ramakrishnan, S., Anand, V., & Roy, S. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9531-7 · Cited by 442
Metadata
- Authors
- Shibuya, M.
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2011-10-03
- Volume
- 2
- Issue
- 12
- Pages
- 1097-1105
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- OpenAlex
- W2138787512
- Cited by
- 1,748
- References
- 66
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.